Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aditxt Inc
ADTX
Healthcare
Biotechnology
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc...
., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. It also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ADTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(305)
•••
whytestocks
X
Post by
whytestocks
on Jul 23, 2024 11:19am
Evofem Signs Phexxi® License Agreement for Middle East
Just In: $ADTX Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 PR Newswire @ Pharma 1
...more
(305)
•••
whytestocks
X
Post by
whytestocks
on Jul 17, 2024 10:00am
Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estim
BREAKING NEWS: $ADTX Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates | BenzingaU.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling around 300 points on
...more
(305)
•••
whytestocks
X
Post by
whytestocks
on May 03, 2024 9:15pm
Aditxt Announces Pricing of $4.2 Million Private Placement P
BREAKING NEWS: $ADTX Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesAditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 08, 2024 8:30am
New Press Release - Aditxt, Inc.'s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic(TM) Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
This strategic acquisition positions Pearsanta for robust growth: expanding opportunities in women’s health, spanning endometriosis to ovarian cancer, and in men’s health starting with prostate cancer Aditxt, Inc. (“Aditxt” or the “Company”) (NASDAQ: ADTX), a company dedicated to discovering...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 05, 2024 8:30am
New Press Release - Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has closed its previously announced private placement for the purchase and sale of an...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 02, 2024 8:30am
New Press Release - Aditxt, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement
Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promising health innovations, today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) Hearing Panel that it has regained compliance with...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 29, 2023 5:07pm
New Press Release - Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules
Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 13, 2023 7:39pm
New Press Release - Lifshitz Law PLLC Announces Investigations of EGLE, ICVX, ADTX, and HOLI
NEW YORK, NY / ACCESSWIRE / December 13, 2023 /Eagle Bulk Shipping Inc. (NYSE:EGLE)Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of EGLE to Star Bulk Carriers Corporation for 2.6211 shares of Star Bulk Carriers Corporation per...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 13, 2023 2:21pm
ADTX ....mini pop on low volume
This should implode any minute
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 13, 2023 12:06pm
New Press Release - SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Aditxt, Inc. Merger
Wilmington, Delaware--(Newsfile Corp. - December 13, 2023) - Rigrodsky Law, P.A. is investigating Aditxt, Inc. ("Aditxt") (NASDAQ: ADTX) regarding possible breaches of fiduciary duties and other violations of law related to Aditxt's agreement to merge with Evofem Biosciences, Inc.To learn more...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 12, 2023 12:46pm
ADTX..... Looks like it's ready to break out to the upside
Me ....no position I do feel that EVFM will follow the up if ADTX break $7
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 12, 2023 10:16am
I dont know if momy let me stay for the after party
You did see it coming incredible!
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 12, 2023 9:53am
New Press Release - ADTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aditxt, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Aditxt, Inc. (NASDAQ: ADTX) and Evofem Biosciences, Inc. is fair to Aditxt shareholders. Halper Sadeh encourages Aditxt shareholders to click here to learn more about their legal rights and options or contact...
read article.
(69)
•••
Iseneschal
X
Comment by
Iseneschal
on Dec 12, 2023 9:32am
RE:ADTX...... Wait for the fireworks...u ain't seen nothin yet
Merry Xmas comes early Yeeha!!!!
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 12, 2023 8:32am
New Press Release - Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
Evofem posted $13.4 million in net sales of Phexxifor the first nine months of 2023;Aditxt looks to accelerate Evofem into the global non-hormonal birth control market valued at $27.7 billion in 2022 and is projected to grow to $52.2 billion by 2031 Aditxt, Inc. (“Aditxt” or the “Company...
read article.
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences